Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

Research paper from Europe PMC. Evidence status: source reported.

Published

2024-01-22

Source reference

MED:38272046

DOI

10.1016/s2352-4642(23)00316-4

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

RECOVERY Collaborative Group. · Lancet Child Adolesc Health · research support, non-u.s. gov't; adaptive clinical trial; randomized controlled trial; journal article · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/38272046. Captured 2026-10-29.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.